Inizio Engage

Our Next Generation commercial approach offers a cutting-edge suite of capabilities with the data-driven insights, planning and activation expertise you need to thrive in the commercial environment. Maximize your commercial success with Inizio Engage. Learn more at https://lnkd.in/gVih5bBt.

Patients with a rare lung disease were dropping out of a support program due to medication side effects and a lengthy treatment regimen, including insurance delays. Our Patient Solutions team activated an early Clinical Educator program and a patient journey workshop resulting in fewer dropouts and a reduction in treatment wait time. In addition to positive patient and care partner feedback, we received a PM360 Magazine Trailblazer Persistence/Adherence Program Gold Award in 2023. Read more about this case study https://lnkd.in/dZ7H265c. #casestudy #patientsolutions #raredisease

Immersing Medical Science Liaison’s (MSLs) into the clinical trial process early has become indispensable for navigating complex studies and facilitating scientific communication. Discover how MSL support can optimize the clinical trial experience: https://lnkd.in/ezx_UYar.

We’re proud to introduce Forty1’s new podcast, The Business of Motivation, in collaboration with Merck (known as MSD outside the US and Canada). This episode features Cesar Fabian Garcia Jimenez, Executive Director of Global Communications at Merck (MSD), alongside Jessica Holt Ph.D. from Forty1’s Behavioral Science division. Hosted by Richelle Feigin, we explore what truly drives employees in 2024 and how organizations can leverage motivation to enhance productivity and engagement. Cesar and Jess break down the five forms of motivation, focusing on Identity Motivation as the most significant driver in 2024. They provide actionable strategies for boosting motivation and performance, along with real-world examples of how to engage and inspire teams, particularly during times of change. If you’re interested in learning how to keep your workforce motivated and thriving, this is an episode you won’t want to miss! Listen now: https://lnkd.in/eADUvDmE. For deeper insights and practical takeaways, download the full report here: https://lnkd.in/edQhJ-EF.

Nazaré's webinar is tomorrow! Don’t miss out on tomorrow's webinar where the Nazaré team will REVEAL new research and share key insights on bridging the capability gap for commercial, medical, and market access teams. Join Terri Harchar, Georgette Humphrey and Stephanie Plowright to learn how you can make the future of field excellence a reality sooner than expected. Haven’t registered yet? There’s still time! Register here: https://lnkd.in/eAs56mWb. Looking forward to seeing you there!

Our Patient Access specialists are uniquely positioned to minimize the impact of annual reverification on treatment access and patient adherence. They collaborate with your field teams to provide market insights and expert guidance to ensure timely access to patients’ prescribed therapies. Discover the difference with Inizio Engage at https://lnkd.in/euQnQqyV.

Medical Science Liaisons (MSLs) have become key players in the clinical trial process, driving success through expert insights and strategic partnerships. From optimizing trial designs to building strong KOL relationships, MSLs bridge the gap between science and strategy. Discover how MSLs are enhancing clinical trial success in our latest blog: https://lnkd.in/gkPju-rE. #MedicalScienceLiaison #ClinicalTrials #MSL

At Inizio Engage, we’re passionate about helping people thrive, which is why we’re excited to introduce Forty1, our brand focused on employee experience. From creating clear communications and listening to employees, to building strong EVPs and fostering belonging, Forty1 helps organizations connect with their people in meaningful ways. Whether navigating change or strengthening everyday culture, they know how to boost engagement and performance. Discover how Forty1 can help your business succeed: www.forty1.com.

The lack of diversity in clinical trials is a global concern, the role of Medical Science Liaisons (MSLs) is evolving to meet this critical challenge. In this article, Jeff Vaughan explains how MSLs are driving inclusivity by building trust, fostering collaboration, and engaging underserved communities in clinical research. This shift not only promotes health equity but also ensures that research outcomes are reflective of real-world diversity. Read more about how MSLs are shaping the future of inclusive clinical research at https://lnkd.in/eRxtRV2M. #DiversityInResearch #ClinicalTrials #MSLImpact #HealthEquity #PatientEngagement

By combining data-driven insights, planning and activation expertise we ensure that you can respond quickly to the ever-changing commercial environment, build stronger connections with your customers and maximize commercial success. Learn more about our custom approach at https://lnkd.in/eu8-kqKY.